Clinical trial
Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH)…
NCT00169637 · Hospices Civils de Lyon, Other · Completed
Key facts
| NCT number | NCT00169637 |
|---|---|
| Title | Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome |
| Official title | Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Short Bowel Syndrome |
| Intervention type | Drug |
| Interventions | rhGH |
| Enrollment | 14 |
| Start date | Jun 1, 2006 |
| Completion | Jun 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 31, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: